Search

Eric W. Thomas

Examiner (ID: 13097, Phone: (571)272-1985 , Office: P/2848 )

Most Active Art Unit
2848
Art Unit(s)
2831, 2848, 2835
Total Applications
2348
Issued Applications
1918
Pending Applications
165
Abandoned Applications
302

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6290044 [patent_doc_number] => 20100158938 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => 'Tetravalent Dengue Vaccines' [patent_app_type] => utility [patent_app_number] => 12/471962 [patent_app_country] => US [patent_app_date] => 2009-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 32796 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20100158938.pdf [firstpage_image] =>[orig_patent_app_number] => 12471962 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/471962
Tetravalent Dengue Vaccines May 25, 2009 Abandoned
Array ( [id] => 6588136 [patent_doc_number] => 20100291540 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'CARBOHYDRATE BINDING MODULE AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/464788 [patent_app_country] => US [patent_app_date] => 2009-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 4138 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20100291540.pdf [firstpage_image] =>[orig_patent_app_number] => 12464788 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/464788
CARBOHYDRATE BINDING MODULE AND USE THEREOF May 11, 2009 Abandoned
Array ( [id] => 8834301 [patent_doc_number] => 08450056 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-28 [patent_title] => 'Arrayed imaging reflectometry (AIR) sensor chip comprising virus-like particles suitable for the detection of antiviral immune responses' [patent_app_type] => utility [patent_app_number] => 12/434298 [patent_app_country] => US [patent_app_date] => 2009-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 9313 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 144 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12434298 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/434298
Arrayed imaging reflectometry (AIR) sensor chip comprising virus-like particles suitable for the detection of antiviral immune responses Apr 30, 2009 Issued
Array ( [id] => 8920688 [patent_doc_number] => 08486619 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-16 [patent_title] => 'Arrayed imaging reflectometry (air) sensor chip comprising influenza hemagglutinin (HA) polypeptides suitable for the detection of antiviral immune responses' [patent_app_type] => utility [patent_app_number] => 12/434438 [patent_app_country] => US [patent_app_date] => 2009-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 22 [patent_no_of_words] => 13956 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12434438 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/434438
Arrayed imaging reflectometry (air) sensor chip comprising influenza hemagglutinin (HA) polypeptides suitable for the detection of antiviral immune responses Apr 30, 2009 Issued
Array ( [id] => 5936014 [patent_doc_number] => 20110212118 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'TAT Protein for preventing or treating AIDS' [patent_app_type] => utility [patent_app_number] => 12/989165 [patent_app_country] => US [patent_app_date] => 2009-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14478 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20110212118.pdf [firstpage_image] =>[orig_patent_app_number] => 12989165 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/989165
Modified Tat Oyi protein with enhanced immunogenicity Apr 21, 2009 Issued
Array ( [id] => 5936014 [patent_doc_number] => 20110212118 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'TAT Protein for preventing or treating AIDS' [patent_app_type] => utility [patent_app_number] => 12/989165 [patent_app_country] => US [patent_app_date] => 2009-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14478 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20110212118.pdf [firstpage_image] =>[orig_patent_app_number] => 12989165 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/989165
Modified Tat Oyi protein with enhanced immunogenicity Apr 21, 2009 Issued
Array ( [id] => 7487513 [patent_doc_number] => 20110236409 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'OVERLAPPING PEPTIDES FROM VARIABLE ANTIGENS, T CELL POPULATIONS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/936370 [patent_app_country] => US [patent_app_date] => 2009-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 12701 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0236/20110236409.pdf [firstpage_image] =>[orig_patent_app_number] => 12936370 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/936370
OVERLAPPING PEPTIDES FROM VARIABLE ANTIGENS, T CELL POPULATIONS AND USES THEREOF Mar 29, 2009 Abandoned
Array ( [id] => 6024305 [patent_doc_number] => 20110052631 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'INDUCTION OF PROLIFERATION, EFFECTOR MOLECULE EXPRESSION, AND CYTOLYTIC CAPACITY OF HIV-SPECIFIC CD8+ T CELLS' [patent_app_type] => utility [patent_app_number] => 12/934522 [patent_app_country] => US [patent_app_date] => 2009-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 15468 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20110052631.pdf [firstpage_image] =>[orig_patent_app_number] => 12934522 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/934522
INDUCTION OF PROLIFERATION, EFFECTOR MOLECULE EXPRESSION, AND CYTOLYTIC CAPACITY OF HIV-SPECIFIC CD8+ T CELLS Mar 24, 2009 Abandoned
Array ( [id] => 8188356 [patent_doc_number] => 08182820 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-22 [patent_title] => 'Method for inducing cross-reactive immune responses to the human immunodeficiency virus (HIV) in a host by administering feline immunodeficiency virus (FIV) capsid (CA) or reverse transcriptase (RT) immunogens' [patent_app_type] => utility [patent_app_number] => 12/407730 [patent_app_country] => US [patent_app_date] => 2009-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 42 [patent_no_of_words] => 14235 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/182/08182820.pdf [firstpage_image] =>[orig_patent_app_number] => 12407730 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/407730
Method for inducing cross-reactive immune responses to the human immunodeficiency virus (HIV) in a host by administering feline immunodeficiency virus (FIV) capsid (CA) or reverse transcriptase (RT) immunogens Mar 18, 2009 Issued
Array ( [id] => 5342395 [patent_doc_number] => 20090181045 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-16 [patent_title] => 'TAT-BASED VACCINE COMPOSITIONS AND METHODS OF MAKING AND USING SAME' [patent_app_type] => utility [patent_app_number] => 12/405086 [patent_app_country] => US [patent_app_date] => 2009-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 9687 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20090181045.pdf [firstpage_image] =>[orig_patent_app_number] => 12405086 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/405086
TAT-BASED VACCINE COMPOSITIONS AND METHODS OF MAKING AND USING SAME Mar 15, 2009 Abandoned
Array ( [id] => 6245989 [patent_doc_number] => 20100136098 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'AVIAN INFLUENZA VACCINE' [patent_app_type] => utility [patent_app_number] => 12/400269 [patent_app_country] => US [patent_app_date] => 2009-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11981 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20100136098.pdf [firstpage_image] =>[orig_patent_app_number] => 12400269 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/400269
Immunogenic compositions comprising liposomes and an influenza PB2 CTL epitope obtained from the highly pathogenic H5N1 strain Mar 8, 2009 Issued
Array ( [id] => 7514933 [patent_doc_number] => 08039003 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-18 [patent_title] => 'Recombinant attenuated dengue viruses comprising a deletion in the 3′ untranslated region and additional attenuating mutations induced by chemical mutagenesis' [patent_app_type] => utility [patent_app_number] => 12/396376 [patent_app_country] => US [patent_app_date] => 2009-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 14 [patent_no_of_words] => 53366 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/039/08039003.pdf [firstpage_image] =>[orig_patent_app_number] => 12396376 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/396376
Recombinant attenuated dengue viruses comprising a deletion in the 3′ untranslated region and additional attenuating mutations induced by chemical mutagenesis Mar 1, 2009 Issued
Array ( [id] => 5479628 [patent_doc_number] => 20090202585 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'TAT-BASED TOLEROGEN COMPOSITIONS AND METHODS FOR MAKING AND USING SAME' [patent_app_type] => utility [patent_app_number] => 12/395975 [patent_app_country] => US [patent_app_date] => 2009-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 11431 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20090202585.pdf [firstpage_image] =>[orig_patent_app_number] => 12395975 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/395975
TAT-BASED TOLEROGEN COMPOSITIONS AND METHODS FOR MAKING AND USING SAME Mar 1, 2009 Abandoned
Array ( [id] => 6323672 [patent_doc_number] => 20100196992 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-05 [patent_title] => 'INTERGENIC REGIONS AS NOVEL SITES FOR INSERTION OF HIV DNA SEQUENCES IN THE GENOME OF MODIFIED VACCINIA VIRUS ANKARA' [patent_app_type] => utility [patent_app_number] => 12/393861 [patent_app_country] => US [patent_app_date] => 2009-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 19149 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20100196992.pdf [firstpage_image] =>[orig_patent_app_number] => 12393861 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/393861
Recombinant modified vaccinia virus ankara (MVA) comprising human immunodeficiency virus (HIV) genes inserted into one or more intergenic regions (IGRs) Feb 25, 2009 Issued
Array ( [id] => 6228925 [patent_doc_number] => 20100183663 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'INTERGENIC REGIONS AS NOVEL SITES FOR INSERTION OF HIV DNA SEQUENCES IN THE GENOME OF MODIFIED VACCINIA VIRUS ANKARA' [patent_app_type] => utility [patent_app_number] => 12/393840 [patent_app_country] => US [patent_app_date] => 2009-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 19124 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20100183663.pdf [firstpage_image] =>[orig_patent_app_number] => 12393840 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/393840
Methods for inducing an immune response in a host comprising administering modified vaccinia virus ankara (MVA) recombinants comprising human immunodeficiency virus (HIV) genes inserted into one or more intergenic regions (IGRs) Feb 25, 2009 Issued
Array ( [id] => 6135216 [patent_doc_number] => 20110008889 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'SERPIN DRUGS FOR TREATMENT OF HIV INFECTION AND METHOD OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/391669 [patent_app_country] => US [patent_app_date] => 2009-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 16950 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20110008889.pdf [firstpage_image] =>[orig_patent_app_number] => 12391669 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/391669
SERPIN DRUGS FOR TREATMENT OF HIV INFECTION AND METHOD OF USE THEREOF Feb 23, 2009 Abandoned
Array ( [id] => 5545897 [patent_doc_number] => 20090155774 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'Fluorescence resonance energy transfer screening assay for the identification of HIV-1 envelope glycoprotein-medicated cell' [patent_app_type] => utility [patent_app_number] => 12/378572 [patent_app_country] => US [patent_app_date] => 2009-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 15596 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20090155774.pdf [firstpage_image] =>[orig_patent_app_number] => 12378572 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/378572
Fluorescence resonance energy transfer screening assay for the identification of HIV-1 envelope glycoprotein-medicated cell Feb 16, 2009 Abandoned
Array ( [id] => 6212908 [patent_doc_number] => 20110136208 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-09 [patent_title] => 'ANTIGEN-SPECIFIC REGULATORY T-CELL INDUCTION' [patent_app_type] => utility [patent_app_number] => 12/867703 [patent_app_country] => US [patent_app_date] => 2009-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11863 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20110136208.pdf [firstpage_image] =>[orig_patent_app_number] => 12867703 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/867703
ANTIGEN-SPECIFIC REGULATORY T-CELL INDUCTION Feb 12, 2009 Abandoned
Array ( [id] => 5391217 [patent_doc_number] => 20090208530 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'HIV polynucleotides and polypeptides derived from Botswana MJ4' [patent_app_type] => utility [patent_app_number] => 12/365215 [patent_app_country] => US [patent_app_date] => 2009-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 24747 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20090208530.pdf [firstpage_image] =>[orig_patent_app_number] => 12365215 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/365215
HIV polynucleotides and polypeptides derived from Botswana MJ4 Feb 3, 2009 Abandoned
Array ( [id] => 5397356 [patent_doc_number] => 20090317419 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'Tetramers' [patent_app_type] => utility [patent_app_number] => 12/320709 [patent_app_country] => US [patent_app_date] => 2009-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 18748 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20090317419.pdf [firstpage_image] =>[orig_patent_app_number] => 12320709 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/320709
Tetramers Feb 1, 2009 Abandoned
Menu